Patient-informed clinical trial development with Victoria DiBiaso, VP & Global Head Patient Informed Development & Health Value Translation at Sanofi

Today’s episode features Victoria DiBiaso from Sanofi. Victoria provides a detailed analysis of patient-informed development and the critical importance of diversity and inclusion in clinical trials. With her unique perspective stemming from her nursing background, she explains the significance of patient-centric trials and the future of healthcare.

Throughout the episode, Victoria elaborates on effective communication with patient communities, the significance of trust-building, and how understanding social determinants of health can aid in forging strong relationships with patient advisors. The episode further explores the world of drug development, from considering patient-relevant endpoints to health scales and label opportunities.

Topics Discussed:

• (00:00:00) Introduction
• (00:00:51) Victoria’s background and how she ended up in her current role
• (00:02:32) An explanation of patient-informed development
• (00:03:48) The meaning of patient centricity
• (00:06:13) Stumbling blocks to patient centricity